Quantification of circulating activated protein C in human plasma by immunoassays - Enzyme levels are proportional to total protein C levels

Thrombosis and Haemostasis

Volumn 75, Issue 1, 1996, Pages 56-61

  España, Francisco ^a   Zuazu, Isabel ^b   Vicente, Vicente ^b   Estellés, Amparo ^a   Marco, Pascual ^c   Aznar, Justo ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Medicine School at Catholic University   (Spain)

^c GENERAL HOSPITAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALPHA 1 ANTITRYPSIN; ANTIGEN; CITRIC ACID; ENZYME; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 3;

ACCURACY; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX FORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TIME;

EID: 0030033126     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650221     Document Type: Article

References (39)

1. Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-31.
2. Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolydc inactivation of human Factor VIII procoagulant protein by activated human protein C and its analogy with Factor V. Blood 1984; 63: 486-9.
3. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-3.
4. Branson H, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and a coumarin-responsive chronic relapsing purpura fulminans syndrome in a neonate. Lancet 1983; 2: 1165-8.
5. Estellés A, García-Plaza I, Dasí A, Aznar J, Duart M, Sanz G. Pérez-Requejo JL, España F, Jimenez C, Abeledo G. Severe inherited "homozygous" protein C deficiency in a newborn infant. Thromb Haemost 1984; 52. 53-6.
6. Gruber A, Griffin JH, Harker LA, Hanson SR. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 1989; 3: 639-42.
7. Wydro R, Oppenheimer C, Rodger R, Niemi S. Recombinant activated protein C prevents occlusion in an arterio-venous shunt. Fibrinolysis 1988; 2 (Suppl 1): 4a (abstr).
8. Graber A, Hanson SR, Kelly AB, Yan BS, Bang N, Griffin JH, Harker LA. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis Circulation 1990; 82; 578-85.
9. Taylor FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-25.
10. Okajima K, Imamura H, Koga S, Inoue M, Takatsuki K, Aoki N. Treatment of patients with disseminated intravascular coagulation by protein C. Amer J Hematol 1990; 33:277-8.
11. Dreyfus M, Magny JF, Bridey F, Schwartz HP, Planché C, Dehan M, Tchernia G. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-8.
12. Bauer KA, Kass BL, Beeler DL, Rosenberg RD. Detection of protein C activation in humans. J Clin Invest 1984; 74: 2033-41.
13. Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 1989; 73: 455-61.
14. Heeb MJ, España F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood 1989; 73: 446-54.
15. España F, Vicente V, Tabernero D, Scharrer I, Griffin JH. Determination of plasma protein C inhibitor and of two activated protein C-inbibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res 1990; 59: 593-608.
16. Gruber A, Griffin JH. Direct detection of activated protein C in blood from human subjects. Blood 1992; 79: 2340-8.
17. Orthner CL, Kolen B, Drohan WN. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo. Thromb Haemost 1993; 69: 441-7.
18. España F, Berrettini M, Griffin JH Purification and characterization of plasma protein C inhibitor. Thromb Res 1989; 55: 369-84.
19. España F, Griffin JH. Determination of functional and antigen protein C inhibitor and its complexes with activated protein C in plasma by ELISA's. Thromb Res 1989; 55: 671-82.
20. Hendl S, España F, Aznar J, Estellés A, Gilabert J, Griffin JH. Immunoaffinity purification of protein C with a calcium-dependent monoclonal antibody. Rev Iberoamer Tromb Haemost 1991; 4: 25-8.
21. España F, Estellés A, Aznar J, Gilabert J. Assay of protein C in human plasma: Comparison of amidolytic, coagulation and immunochemical assays. Thromb Res 1986; 44: 771-82.
22. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor: Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-8.
23. Heeb MJ, Griffin JH. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin. J Biol Chem 1988; 263: 11613-6.
24. España F. Complexes of activated protein C with its inhibitors, in Aznar J, España F (eds): Protein C pathway. Barcelona - Berlin, Springer-Verlag, 1991, pp 61-75.
25. Tabernero D, España F, Vicente V, Estellés A, Gilabert J, Aznar J. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment. Thromb Haemost 1990; 63: 380-2.
26. Vicente V, España F, Tabernero D, Aznar J, Estellés A, Griffin JH. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever. Blood 1991; 78: 416-22.
27. España F, Gruber A, Heeb MJ, Hanson SR, Harker LA, Griffin JH. In vivo and in vitro complexes of activated protein C with two inhibitors in baboon. Blood 1991; 77: 1754-60.
28. Sheth SB, Carvalho AC. Protein S and C alterations in acutely ill patients. Amer J Hematol 1991; 36: 14-9.
29. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of E. coli infusion in the baboon. J Clin Invest 1987; 79: 918-25.
30. Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992; 12: 135-45
31. Snow TR, Deal MT, Dickey DT, Esmon CT. Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation 1991; 84: 293-9.
32. España F, Vicente V, Vazquez L, Estellés A, Sánchez-Cuenca J, Aznar J. Activation of protein C and complex formation between protein C inhibitor and tissue plasminogen activator during thrombolytic therapy. Fibrinolysis 1993; 7: 308-15.
33. Gruber A, Pal A, Kiss RG, Sas G, Griffin JH. Generation of activated pro-tein C during thrombolysis. Lancet 1993; 342: 1275-6.
34. 1AT) complex as a marker for in vitro diagnosis of prethrombotic states. Thromb Res 1992; 66: 499-508.
35. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
36. Koster T, Roosendal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina R. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden thrombophilia study. Lancet 1993; 342: 1503-6.
37. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-93.
38. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22.
39. Bauer KA, Broekmans AW, Bertina RM, Conard J, Horellou M, Samama MM, Rosenberg RD. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 1988; 71: 1418-26.